Addictions, Drug & Alcohol Institute

Front Page


June 17, 2024

Third Space Toolkit: New Resource from ADAI’s CAAHS Supporting Telehealth for Substance Use Disorders

Third Space Toolkit

ADAI’s Center for Advancing Addiction Health Services (CAAHS), working with the Idaho Department of Health and Welfare, recently developed an interactive online toolkit, the Third Space Toolkit: Building Space for Telehealth in Libraries and the Community, to support the addition of “privacy pods” in Idaho public libraries for the purpose of providing private spaces for…


Congratulations to Our ADAI Spring Small Grants Awardees!

ADAI Small Grants Spring Cycle Awardees

What are ADAI Small Grants? ADAI works to stimulate and facilitate UW research on alcohol and drug use and addiction through its Small Grants Program, which awards funds to UW researchers for pilot studies and developmental research. The scope ranges from pharmacology of drugs to studies of clinical treatment strategies, prevention, and social policy issues….


June 14, 2024

Slides Available: What’s in the Drug Supply: Updates from the WA State Community Drug Checking Network

What's in the Drug Supply? Webinar June 12, 2024, 2-3pm PT.

Update: This event was held on June 12, 2024. The slides are now available. The WA State Community Drug Checking Network (CDCN) is a partnership of organizations that provide community-level drug checking and harm reduction services. The ADAI Center for Community-Engaged Drug Education, Epidemiology, and Research (CEDEER) provides support including technical assistance and state-level data on the drug…


June 11, 2024

New ADAI Publications on Cannabis and Opioid Policy

New publications

Several ADAI researchers have some new publications out recently related to cannabis and opioid policy: State Requirements for Non-Medical Cannabis “Budtenders” Beatriz Carlini, PhD, MPH, Research Associate Professor and Director of ADAI’s Cannabis Education & Research Program, is coauthor of a new paper on State requirements for non-medical US cannabis retail personnel (LoParco C, et…


June 3, 2024

Recording available: Safe Supply: What is it? Do people want it? What impacts could it have?

Safe Supply webinar: May 30, 2024

Update: This event was held on May 30, 2024. Find the recording and slides here. Overdoses and health problems among people who use drugs are increasing. Safe supply models provide a regulated and known dose of opioids to reduce negative health consequences. In this webinar we’ll explore: Presenters:Addie Palayew, MsC, PhDc, & Caleb Banta-Green, PhD, MPH, MSW, UW ADAI…


May 29, 2024

2024 ADAI WA State Legislative Wrap-Up

2024 ADAI WA State Legislative Wrap-Up

During the 2024 state legislative session, two bills passed the Washington State Legislature and were signed by the Governor that involved ADAI. Following is a summary of the two bills. 2SHB 2320: An act relating to reducing the public health harms associated with high THC cannabis products ADAI’s Cannabis Education and Research Program’s (CERP) research…


May 23, 2024

Front Lines of the Fentanyl Crisis: Dr. Caleb Banta-Green testifies to U.S. Senate Finance Committee, Fatal Overdose Reduction Act Introduced

Front Lines of the Fentanyl Crisis: Committee Hearing

ADAI Research Professor, Caleb Banta-Green, PhD, MPH, MSW, Director of the Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER), flew to Washington D.C. this week to testify in front of the U.S. Senate Finance Committee for a special hearing titled “Front Lines of the Fentanyl Crisis: Supporting Communities and Combating Addiction through Prevention and…


May 8, 2024

ADAI in the News – Cannabis Edition

Hand holding cell phone with website loaded on the screen reading NEWS at the top

ADAI’s Director, Susan Ferguson, PhD, was recently featured in two news pieces about the U.S. Drug Enforcement Administration’s move toward reclassifying cannabis as a less dangerous drug by lowering it from Schedule I to Schedule III. (What do these terms mean?) In an article for the AP that discusses numerous impacts such a change might…


May 6, 2024

Two New Reports from ADAI CEDEER: Kratom and Contingency Management

Stack of 3 binders with New ADAI Report on the spines

ADAI’s Center for Community-Engaged Drug Education, Epidemiology, and Research (CEDEER) has two new reports out this week! Kratom: What do we know about its use, safety, and overdose risk? Mandy Sladky, MSN, RN, CARN, and Caleb Banta-Green, PhD, MPH, MSW Kratom is a psychoactive substance made from the leaves of the Mitragyna speciosa tree that…


April 22, 2024

Results from the 2023 WA State Syringe Services Program Health Survey

New from ADAI: Results from the 2023 WA Syringe Services Program Health Survey

Involving people who use drugs in meaningful ways to design and deliver the services offered to them is important. People who use drugs have clear preferences, insights, and innovative ideas for service models and are eager to share their perspectives when given genuine opportunities for input and involvement. To capture some of that vital information,…



Next page